Supernus Pharmaceuticals, Inc. (SUPN)
45.36
+0.26
(+0.57%)
USD |
NASDAQ |
Aug 25, 16:00
45.36
0.00 (0.00%)
After-Hours: 19:48
Supernus Pharmaceuticals Total Return Level : 45.11 for Aug. 24, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 24, 2026 | 45.11 |
| August 21, 2026 | 45.85 |
| August 20, 2026 | 47.45 |
| August 19, 2026 | 48.54 |
| August 18, 2026 | 49.03 |
| August 17, 2026 | 48.27 |
| August 14, 2026 | 48.27 |
| August 13, 2026 | 47.15 |
| August 12, 2026 | 47.87 |
| August 11, 2026 | 46.88 |
| August 10, 2026 | 47.07 |
| August 07, 2026 | 47.64 |
| August 06, 2026 | 46.76 |
| August 05, 2026 | 46.91 |
| August 04, 2026 | 43.25 |
| August 03, 2026 | 46.00 |
| July 31, 2026 | 44.63 |
| July 30, 2026 | 45.61 |
| July 29, 2026 | 46.57 |
| July 28, 2026 | 47.73 |
| July 27, 2026 | 46.98 |
| July 24, 2026 | 46.20 |
| July 23, 2026 | 47.19 |
| July 22, 2026 | 46.94 |
| July 21, 2026 | 47.87 |
| Date | Value |
|---|---|
| July 20, 2026 | 47.42 |
| July 17, 2026 | 48.04 |
| July 16, 2026 | 48.21 |
| July 15, 2026 | 47.73 |
| July 14, 2026 | 46.66 |
| July 13, 2026 | 47.35 |
| July 10, 2026 | 48.46 |
| July 09, 2026 | 48.75 |
| July 08, 2026 | 50.44 |
| July 07, 2026 | 47.94 |
| July 06, 2026 | 47.24 |
| July 02, 2026 | 48.05 |
| July 01, 2026 | 47.41 |
| June 30, 2026 | 46.51 |
| June 29, 2026 | 46.80 |
| June 26, 2026 | 46.84 |
| June 25, 2026 | 44.75 |
| June 24, 2026 | 45.14 |
| June 23, 2026 | 44.48 |
| June 22, 2026 | 44.48 |
| June 18, 2026 | 44.38 |
| June 17, 2026 | 43.58 |
| June 16, 2026 | 43.58 |
| June 15, 2026 | 43.86 |
| June 12, 2026 | 44.41 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Indivior Pharmaceuticals, Inc. | 37.63 |
| Pfizer Inc. | 93.56 |
| Amphastar Pharmaceuticals, Inc. | 21.52 |
| Collegium Pharmaceutical, Inc. | 27.35 |
| Bristol Myers Squibb Co. | 254.55 |